ciprofloxacin and ambroxol

ciprofloxacin has been researched along with ambroxol in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Bao, L; Lu, Q; Ran, T; Yu, J; Zhong, H1
Cheng, C; Du, L; He, Y; Lu, Q; Ran, T; Yu, J1
He, Y; Li, F; Wang, W; Wang, Z; Yu, J1

Other Studies

4 other study(ies) available for ciprofloxacin and ambroxol

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Effects of combined treatment with ambroxol and ciprofloxacin on catheter-associated Pseudomonas aeruginosa biofilms in a rat model.
    Chemotherapy, 2013, Volume: 59, Issue:1

    Topics: Ambroxol; Animals; Anti-Bacterial Agents; Biofilms; Catheters; Ciprofloxacin; Disease Models, Animal; Drug Therapy, Combination; Intubation, Intratracheal; Lung; Microscopy, Electron, Scanning; Pseudomonas aeruginosa; Pseudomonas Infections; Rats; Respiratory Tract Infections

2013
Ciprofloxacin plus erythromycin or ambroxol ameliorates endotracheal tube-associated Pseudomonas aeruginosa biofilms in a rat model.
    Pathology, research and practice, 2015, Volume: 211, Issue:12

    Topics: Ambroxol; Animals; Anti-Bacterial Agents; Biofilms; Catheters, Indwelling; Ciprofloxacin; Disease Models, Animal; Drug Therapy, Combination; Erythromycin; Female; Male; Prosthesis-Related Infections; Pseudomonas aeruginosa; Pseudomonas Infections; Rats; Rats, Sprague-Dawley; Respiration, Artificial

2015
Ambroxol inhibits mucoid conversion of Pseudomonas aeruginosa and contributes to the bactericidal activity of ciprofloxacin against mucoid P. aeruginosa biofilms.
    APMIS : acta pathologica, microbiologica, et immunologica Scandinavica, 2016, Volume: 124, Issue:7

    Topics: Ambroxol; Anti-Bacterial Agents; Biofilms; Ciprofloxacin; Drug Synergism; Expectorants; Humans; Hydrogen Peroxide; Infant, Newborn; Microbial Viability; Polysaccharides, Bacterial; Pseudomonas aeruginosa; Topoisomerase II Inhibitors

2016